chimeras

Biologists at Stanford University have developed the LYTAC, a new class of drug that might be the future of therapeutics due to its ability to breakdown previously un-accessible proteins on cell walls and its adaptability.

by Garrett Dunlap figures by Shannon McArdel Every ten minutes, another person joins the list of hundreds of thousands waiting for organ transplants. The wait is sometimes years long, despite many of the candidates being in critical condition. But what…

by Caitlin Nichols cover image by Rebecca Clements Modern advances in stem cell technology and genetic engineering are bringing the stuff of science fiction into reality, presenting remarkable promise for expanding knowledge and treating disease.…